Chernov, A.N.; Skliar, S.S.; Kim, A.V.; Tsapieva, A.; Pyurveev, S.S.; Filatenkova, T.A.; Matsko, M.V.; Ivanov, S.D.; Shamova, O.V.; Suvorov, A.N.
Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients. Pharmaceutics 2024, 16, 1234.
https://doi.org/10.3390/pharmaceutics16091234
AMA Style
Chernov AN, Skliar SS, Kim AV, Tsapieva A, Pyurveev SS, Filatenkova TA, Matsko MV, Ivanov SD, Shamova OV, Suvorov AN.
Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients. Pharmaceutics. 2024; 16(9):1234.
https://doi.org/10.3390/pharmaceutics16091234
Chicago/Turabian Style
Chernov, Alexander N., Sofia S. Skliar, Alexander V. Kim, Anna Tsapieva, Sarng S. Pyurveev, Tatiana A. Filatenkova, Marina V. Matsko, Sergey D. Ivanov, Olga V. Shamova, and Alexander N. Suvorov.
2024. "Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients" Pharmaceutics 16, no. 9: 1234.
https://doi.org/10.3390/pharmaceutics16091234
APA Style
Chernov, A. N., Skliar, S. S., Kim, A. V., Tsapieva, A., Pyurveev, S. S., Filatenkova, T. A., Matsko, M. V., Ivanov, S. D., Shamova, O. V., & Suvorov, A. N.
(2024). Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients. Pharmaceutics, 16(9), 1234.
https://doi.org/10.3390/pharmaceutics16091234
